Dysbindin‐1 gene contributes differentially to early‐ and adult‐onset forms of functional psychosis

Dysbindin‐1 is a relatively ubiquitous protein in the brain which is involved in the modulation of synaptic homeostasis. The dysbindin‐1 gene (DTNBP1) has been associated with schizophrenia and bipolar disorder diagnoses. However, its contribution to the severity of the clinical and neurocognitive expression of these disorders remains controversial. We aimed to explore the association between DTNBP1 and the phenotypes which are more directly linked with the underlying biology, such as age at onset and neurocognitive impairment. The present family sample comprised 894 Caucasian individuals: 268 patients affected by functional psychosis [58% with illness onset before 18 years, mean age at onset (SD): 14.71 (2.10)], 483 parents and 143 siblings. Ten DTNBP1 single nucleotide polymorphisms were genotyped in all individuals and their transmission disequilibrium was tested in relation to: (i) the risk for psychosis; (ii) patients' age at onset; and (iii) familial neurocognitive performance (including IQ estimation and executive functioning). In early‐onset families a 5‐marker haplotype encompassing exons 2–4 and the surrounding introns was significantly over‐transmitted to cases, while in adult‐onset families two haplotypes corresponding to the region between introns 4 and 7 were over‐transmitted to cases. Estimated IQ was associated with the rs760666 marker in the whole sample, whereas a significant association between executive functioning and the rs2619522 marker appeared in early‐onset families. Our findings confirm the role of the dysbindin‐1 gene in the risk for functional psychosis and show a differential haplotypic risk pattern in families with early as opposed to adult onset in the affected offspring. © 2011 Wiley‐Liss, Inc.

[1]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[2]  R. Pratt Genetic aspects. , 1962, Proceedings of the Royal Society of Medicine.

[3]  Eric A Youngstrom,et al.  A quantitative and qualitative review of neurocognitive performance in pediatric bipolar disorder. , 2008, Journal of child and adolescent psychopharmacology.

[4]  D. Wedding Halstead‐Reitan Neuropsychological Test Battery , 2010 .

[5]  R. Hashimoto,et al.  Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin. , 2006, Biochemical and biophysical research communications.

[6]  Zhongming Zhao,et al.  The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample , 2009, Schizophrenia Research.

[7]  E. Bora,et al.  Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. , 2009, Journal of affective disorders.

[8]  Thomas G Schulze,et al.  The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. , 2003, American journal of human genetics.

[9]  B. Birmaher,et al.  Pediatric bipolar disorder: a review of the past 10 years. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

[10]  Carlo Colantuoni,et al.  Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex , 2008, Brain Structure and Function.

[11]  Nick Craddock,et al.  Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or "schizoaffective") psychoses. , 2009, Schizophrenia bulletin.

[12]  R. Straub,et al.  A potential vulnerability locus for schizophrenia on chromosome 6p24–22: evidence for genetic heterogeneity , 1995, Nature Genetics.

[13]  Carlo Caltagirone,et al.  Reduced Occipital and Prefrontal Brain Volumes in Dysbindin-Associated Schizophrenia , 2010, Neuropsychopharmacology.

[14]  A. Nierenberg,et al.  Long-Term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD) , 2004, Biological Psychiatry.

[15]  R. Huganir,et al.  Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. , 2005, American journal of human genetics.

[16]  J. Bertranpetit,et al.  Principal component analysis of gene frequencies and the origin of Basques. , 1994, American journal of physical anthropology.

[17]  D. Blake,et al.  Dysbindin, a Novel Coiled-coil-containing Protein That Interacts with the Dystrobrevins in Muscle and Brain* , 2001, The Journal of Biological Chemistry.

[18]  D. Collier,et al.  Association of the dysbindin gene with bipolar affective disorder. , 2006, The American journal of psychiatry.

[19]  F. Dudbridge Pedigree disequilibrium tests for multilocus haplotypes , 2003, Genetic epidemiology.

[20]  Kirwin,et al.  Behavioral and Brain Functions Failure to Confirm Allelic and Haplotypic Association between Markers at the Chromosome 6p22.3 Dystrobrevin-binding Protein 1 (dtnbp1) Locus and Schizophrenia , 2022 .

[21]  N. Craddock,et al.  Cis- and trans- loci influence expression of the schizophrenia susceptibility gene DTNBP1. , 2008, Human molecular genetics.

[22]  Jeffrey A. Lieberman,et al.  Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory , 2000, Schizophrenia Research.

[23]  R. Straub,et al.  Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients , 2008, Schizophrenia Research.

[24]  P. DeRosse,et al.  Dysbindin genotype and negative symptoms in schizophrenia. , 2006, The American journal of psychiatry.

[25]  Margot Albus,et al.  Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. , 2003, American journal of human genetics.

[26]  Mark J Daly,et al.  Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia. , 2006, American journal of human genetics.

[27]  M. Rutter,et al.  Continuities and discontinuities in psychopathology between childhood and adult life. , 2006, Journal of child psychology and psychiatry, and allied disciplines.

[28]  Takahisa Taguchi,et al.  Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. , 2004, Human molecular genetics.

[29]  Danielle Posthuma,et al.  A genomewide scan for intelligence identifies quantitative trait loci on 2q and 6p. , 2005, American journal of human genetics.

[30]  Heikki Mannila,et al.  Mixture Model Clustering of Phenotype Features Reveals Evidence for Association of DTNBP1 to a Specific Subtype of Schizophrenia , 2009, Biological Psychiatry.

[31]  J L Rapoport,et al.  Research update: childhood-onset schizophrenia: implications of clinical and neurobiological research. , 1998, Journal of child psychology and psychiatry, and allied disciplines.

[32]  H. Nicolini,et al.  Heritability of age of onset of psychosis in schizophrenia , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[33]  Brien P. Riley,et al.  Allelic Heterogeneity in Genetic Association Meta-Analysis: An Application to DTNBP1 and Schizophrenia , 2009, Human Heredity.

[34]  Arthur W Toga,et al.  DTNBP1 is associated with imaging phenotypes in schizophrenia , 2009, Human brain mapping.

[35]  Y. Hosoi,et al.  Dysbindin-1, a Schizophrenia-Related Protein, Functionally Interacts with the DNA- Dependent Protein Kinase Complex in an Isoform-Dependent Manner , 2009, PloS one.

[36]  N C Andreasen,et al.  The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. , 1992, Archives of general psychiatry.

[37]  A. Addington,et al.  Dysbindin (DTNBP1, 6p22.3) is Associated with Childhood-Onset Psychosis and Endophenotypes Measured by the Premorbid Adjustment Scale (PAS) , 2005, Journal of autism and developmental disorders.

[38]  J. Gilmore,et al.  Developmental regulation of neural cell adhesion molecule in human prefrontal cortex , 2009, Neuroscience.

[39]  Birgit Funke,et al.  Genetic variation in DTNBP1 influences general cognitive ability. , 2006, Human molecular genetics.

[40]  Frank Baas,et al.  Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings , 2007, Behavioral and Brain Functions.

[41]  A. Addington,et al.  The neurodevelopmental model of schizophrenia: What can very early onset cases tell us? , 2005, Current psychiatry reports.

[42]  N. Andreasen,et al.  COMPREHENSIVE ASSESSMENT OF SYMPTOMS AND HISTORY (CASH) , 2000 .

[43]  A. Fanous,et al.  Genetics of clinical features and subtypes of schizophrenia: A review of the recent literature , 2008, Current psychiatry reports.

[44]  D. Dickman,et al.  The Schizophrenia Susceptibility Gene dysbindin Controls Synaptic Homeostasis , 2009, Science.

[45]  G. Abecasis,et al.  A general test of association for quantitative traits in nuclear families. , 2000, American journal of human genetics.

[46]  C. Hollis Adolescent schizophrenia , 2000 .

[47]  P. Muglia,et al.  Association of the dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case–control study (BACCS) , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[48]  M. Tohen,et al.  McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. , 2009, The Journal of clinical psychiatry.

[49]  M. Leboyer,et al.  Admixture analysis of age at onset in bipolar I affective disorder. , 2001, Archives of general psychiatry.

[50]  A. Vourdas,et al.  The Maudsley early onset schizophrenia study: cognitive function over a 4-year follow-up period. , 2007, Schizophrenia bulletin.

[51]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[52]  Michael C O'Donovan,et al.  Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. , 2005, Human molecular genetics.

[53]  Wj Gauderman,et al.  QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies , 2006 .

[54]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[55]  Margot Albus,et al.  Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib–pair linkage analysis , 1995, Nature Genetics.

[56]  P. Sham,et al.  The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. , 2003, Archives of general psychiatry.

[57]  S. Arnold,et al.  Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression. , 2009, Human molecular genetics.

[58]  Lin He,et al.  Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. , 2006, Human molecular genetics.

[59]  V. Vallès,et al.  Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. , 2008, Journal of psychiatric research.

[60]  Daniel R Weinberger,et al.  Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. , 2004, Archives of general psychiatry.

[61]  Maria Martinez,et al.  DTNBP1 (Dystrobrevin Binding Protein 1) and Schizophrenia: Association Evidence in the 3′ End of the Gene , 2007, Human Heredity.

[62]  D. Nyholt A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. , 2004, American journal of human genetics.

[63]  J. McClellan,et al.  Early onset psychotic disorders: Diagnostic stability and clinical characteristics , 2009, European Child & Adolescent Psychiatry.

[64]  A G Dean,et al.  Epi Info: a general-purpose microcomputer program for public health information systems. , 1991, American journal of preventive medicine.

[65]  Chanjuan Hao,et al.  DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release , 2008, The Journal of cell biology.

[66]  Birgit Funke,et al.  Association of the DTNBP1 locus with schizophrenia in a U.S. population. , 2004, American journal of human genetics.

[67]  N. Craddock,et al.  Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. , 2005, Schizophrenia bulletin.

[68]  E. Bora,et al.  Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond. , 2010, Schizophrenia bulletin.

[69]  R. Straub,et al.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. , 2002, American journal of human genetics.

[70]  K. Kendler,et al.  The dystrobrevin-binding protein 1 gene: features and networks , 2009, Molecular Psychiatry.

[71]  P. Sullivan,et al.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.

[72]  A. Benton,et al.  COMPARATIVE STUDIES OF SOME PSYCHOLOGICAL TESTS FOR CEREBRAL DAMAGE , 1965, The Journal of nervous and mental disease.

[73]  M. Owen,et al.  Cis-acting variation in the expression of a high proportion of genes in human brain , 2003, Human Genetics.

[74]  W. Sturm,et al.  Neuropsychological assessment , 2007, Journal of Neurology.